These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7166914)

  • 21. A retrospective study of serial CEA determinations in the early detection of recurrent colorectal cancer.
    Wedell J; Meier zu Esssen P; Luu TH; Fiedler R; van Calker H; Koldowski P; Schlipköter HW
    Dis Colon Rectum; 1981; 24(8):618-21. PubMed ID: 7318628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors].
    Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
    Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1963-8. PubMed ID: 4075992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of serial carcinoembryonic antigen determinations for early detection of recurrent cancer.
    Gray BN; Walker C; Barnard R
    Med J Aust; 1981 Feb; 1(4):177-8. PubMed ID: 7231281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
    Lunde OC; Havig O
    Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Carcinoembryonic antigen (CEA) in surgically treated cancer of the large intestine].
    Metzger U; Decurtins M; Joller H; Grob PJ; Largiadèr F
    Schweiz Med Wochenschr; 1983 Apr; 113(15):548-9. PubMed ID: 6857209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined evaluation of postoperative serum levels of carcinoembryonic antigen less than or equal to 2.5 ng/ml and absence of vascular invasion may predict no recurrence of stage I adenocarcinoma lung cancer.
    Kashiwabara K; Saeki S; Sasaki J; Nomura M; Kohrogi H
    J Thorac Oncol; 2008 Dec; 3(12):1416-20. PubMed ID: 19057266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic significance of carcinoembryonic antigen in the plasma and tumors of patients with endometrial adenocarcinoma.
    van Nagell JR; Donaldson ES; Wood EG; Sharkey RM; Goldenberg DM
    Am J Obstet Gynecol; 1977 Jun; 128(3):308-13. PubMed ID: 871143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early detection of recurrence of gastric cancer by serial plasma carcinoembryonic antigen assays.
    Iwamatsu M; Saito T; Matsuguchi T; Tamada R; Soejima K; Inokuchi K
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(3):287-91. PubMed ID: 7459935
    [No Abstract]   [Full Text] [Related]  

  • 29. Relation between Carcinoembryonic Antigen Levels in Colon Cancer Tissue and Serum Carcinoembryonic Antigen Levels at Initial Surgery and Recurrence.
    Saito G; Sadahiro S; Okada K; Tanaka A; Suzuki T; Kamijo A
    Oncology; 2016; 91(2):85-9. PubMed ID: 27260164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked elevation of plasma carcinoembryonic antigen and stomach carcinoma.
    Horie Y; Miura K; Matsui K; Yukimasa A; Ohi S; Hamamoto T; Kawasaki H
    Cancer; 1996 May; 77(10):1991-7. PubMed ID: 8640661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The preoperative and postoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of gastric cancer. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer].
    Sakamoto J; Nakazato H; Toge T; Mai M; Okura H; Kodaira S; Maetani S; Okajima K; Hattori T; Inokuchi K
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1095-104. PubMed ID: 2204669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer.
    Sugarbaker PH; Zamcheck N; Moore FD
    Cancer; 1976 Dec; 38(6):2310-5. PubMed ID: 1000469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Clinical Significance of Serum Carcinoembryonic Antigen in Patients with Resectable Gastric Adenocarcinoma.
    Dang Y; Ouyang X; Wang K; Zhang F; Huang Q
    Arch Med Res; 2016 Apr; 47(3):196-9. PubMed ID: 27387021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures.
    Martin EW; James KK; Hurtubise PE; Catalano P; Minton JP
    Cancer; 1977 Feb; 39(2):440-6. PubMed ID: 837330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer.
    Marrelli D; Pinto E; De Stefano A; Farnetani M; Garosi L; Roviello F
    Am J Surg; 2001 Jan; 181(1):16-9. PubMed ID: 11248169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients.
    Zeng Z; Cohen AM; Urmacher C
    Dis Colon Rectum; 1993 Nov; 36(11):1063-8. PubMed ID: 8223061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer.
    Ikeda Y; Mori M; Kajiyama K; Kamakura T; Maehara Y; Haraguchi Y; Sugimachi K
    Hepatogastroenterology; 1996; 43(11):1281-7. PubMed ID: 8908563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinoembryonic antigen levels of portal blood in gastric cancer patients.
    Tabuchi Y; Deguchi H; Saitoh Y
    J Surg Res; 1989 Jul; 47(1):81-6. PubMed ID: 2739403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
    Körner H; Söreide K; Stokkeland PJ; Söreide JA
    Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
    Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
    Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.